Search research articles
Contact Us
Filters
Showing results (21-30 of 371) with videos related to
Page
of 38
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 1, 1990
Progesterone metabolism in hepatic microsomes. Effect of the cytochrome P-450 inhibitor, ketoconazole, and the NADPH 5 alpha-reductase inhibitor, 4-MA, upon the metabolic profile in human, monkey, dog, and rat
D C Swinney
Clinical Pharmacology and Therapeutics
|
March 21, 2013
Phenotypic vs. target-based drug discovery for first-in-class medicines
D C Swinney
Current Topics in Medicinal Chemistry
|
May 25, 2006
Successful drug discovery
David C Swinney
Physical Review Letters
|
November 20, 1995
Hexagons, kinks, and disorder in oscillated granular layers
Melo, Umbanhowar, Swinney
Clinical Pharmacology and Therapeutics
|
July 10, 2016
Challenges and Hurdles to Business as Usual in Drug Development for Treatment of Rare Diseases
D C Swinney
Current Opinion in Drug Discovery & Development
|
January 20, 2009
The role of binding kinetics in therapeutically useful drug action
David C Swinney
Journal of Biomolecular Screening
|
August 29, 2013
The contribution of mechanistic understanding to phenotypic screening for first-in-class medicines
David C Swinney
Physical Review Letters
|
March 9, 1992
Turbulent flow between concentric rotating cylinders at large Reynolds number
Lathrop, Fineberg, Swinney
Physical Review Letters
|
January 3, 1994
Transition to parametric wave patterns in a vertically oscillated granular layer
Melo, Umbanhowar, Swinney
Expert Opinion on Drug Discovery
|
March 19, 2013
Opportunities to minimise risk in drug discovery and development
David C Swinney
Page
of 38
Search research articles
Search
Showing results (21-30 of 371) with videos related to
Sort By:
Page
of 38
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 1, 1990
Progesterone metabolism in hepatic microsomes. Effect of the cytochrome P-450 inhibitor, ketoconazole, and the NADPH 5 alpha-reductase inhibitor, 4-MA, upon the metabolic profile in human, monkey, dog, and rat
D C Swinney
Clinical Pharmacology and Therapeutics
|
March 21, 2013
Phenotypic vs. target-based drug discovery for first-in-class medicines
D C Swinney
Current Topics in Medicinal Chemistry
|
May 25, 2006
Successful drug discovery
David C Swinney
Physical Review Letters
|
November 20, 1995
Hexagons, kinks, and disorder in oscillated granular layers
Melo, Umbanhowar, Swinney
Clinical Pharmacology and Therapeutics
|
July 10, 2016
Challenges and Hurdles to Business as Usual in Drug Development for Treatment of Rare Diseases
D C Swinney
Current Opinion in Drug Discovery & Development
|
January 20, 2009
The role of binding kinetics in therapeutically useful drug action
David C Swinney
Journal of Biomolecular Screening
|
August 29, 2013
The contribution of mechanistic understanding to phenotypic screening for first-in-class medicines
David C Swinney
Physical Review Letters
|
March 9, 1992
Turbulent flow between concentric rotating cylinders at large Reynolds number
Lathrop, Fineberg, Swinney
Physical Review Letters
|
January 3, 1994
Transition to parametric wave patterns in a vertically oscillated granular layer
Melo, Umbanhowar, Swinney
Expert Opinion on Drug Discovery
|
March 19, 2013
Opportunities to minimise risk in drug discovery and development
David C Swinney
Page
of 38